XTX Topco Ltd Has $2.36 Million Holdings in The Clorox Company (NYSE:CLX)

XTX Topco Ltd lifted its stake in shares of The Clorox Company (NYSE:CLX) by 699.1% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 17,325 shares of the company’s stock after acquiring an additional 15,157 shares during the quarter. XTX Topco Ltd’s holdings in Clorox were worth $2,364,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in CLX. Principal Securities Inc. acquired a new stake in shares of Clorox in the fourth quarter worth $101,000. ING Groep NV increased its stake in shares of Clorox by 170.8% in the fourth quarter. ING Groep NV now owns 1,476 shares of the company’s stock worth $210,000 after purchasing an additional 931 shares during the period. Norges Bank acquired a new position in shares of Clorox during the 4th quarter worth about $128,382,000. BI Asset Management Fondsmaeglerselskab A S grew its holdings in Clorox by 17.6% in the 4th quarter. BI Asset Management Fondsmaeglerselskab A S now owns 4,645 shares of the company’s stock valued at $662,000 after buying an additional 694 shares during the last quarter. Finally, Balentine LLC grew its stake in shares of Clorox by 20.9% in the fourth quarter. Balentine LLC now owns 3,236 shares of the company’s stock worth $461,000 after acquiring an additional 559 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Down 0.8 %

NYSE:CLX opened at $163.43 on Thursday. The stock’s fifty day moving average price is $148.06 and its two-hundred day moving average price is $143.56. The company has a market cap of $20.30 billion, a price-to-earnings ratio of 84.68, a P/E/G ratio of 3.29 and a beta of 0.40. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $169.09. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The business had revenue of $1.90 billion for the quarter, compared to analysts’ expectations of $1.97 billion. On average, analysts anticipate that The Clorox Company will post 6.63 EPS for the current year.

Clorox Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Wednesday, August 14th were issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 2.99%. The ex-dividend date was Tuesday, August 13th. This is a positive change from Clorox’s previous quarterly dividend of $1.20. Clorox’s payout ratio is currently 252.85%.

Insider Buying and Selling at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.51% of the company’s stock.

Wall Street Analysts Forecast Growth

CLX has been the topic of a number of research reports. JPMorgan Chase & Co. lowered their price objective on Clorox from $150.00 to $148.00 and set a “neutral” rating on the stock in a research report on Friday, August 2nd. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a research note on Friday, September 6th. Argus upgraded shares of Clorox to a “hold” rating in a research report on Tuesday, June 4th. Citigroup increased their price target on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Finally, Wells Fargo & Company decreased their price objective on Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a report on Wednesday, July 10th. Six equities research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company. According to data from MarketBeat.com, Clorox presently has an average rating of “Hold” and a consensus target price of $143.50.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.